Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ximing Tang

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Oncotarget|October 20, 2018
Concomitant targeting of the mTOR/MAPK pathways: novel therapeutic strategy in subsets of <i>RICTOR/KRAS</i>-altered non-small cell lung cancerDennis Ruder, Vassiliki Papadimitrakopoulou, Kazuhiko Shien, et al.
Cell Reports|November 18, 2023
Stabilizing vimentin phosphorylation inhibits stem-like cell properties and metastasis of hybrid epithelial/mesenchymal carcinomasNick A Kuburich, Petra den Hollander, Maria Castaneda, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 25, 2019
Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinomaRoberto Ruiz-Cordero, Priya Rao, Lerong Li, et al.
Cancer Discovery|May 16, 2012
The BATTLE trial: personalizing therapy for lung cancerEdward S Kim, Roy S Herbst, Ignacio I Wistuba, et al.
Nature Communications|September 26, 2025
Comparison of imaging based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed paraffin-embedded tumor samplesNejla Ozirmak Lermi, Max Molina Ayala, Sharia Hernandez, et al.
JAMA Oncology|November 6, 2015
Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical TrialWilliam N William, Vassiliki Papadimitrakopoulou, J Jack Lee, et al.
Research Square|January 29, 2025
Comparison of imaging-based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed, paraffin-embedded tumor samplesNejla Ozirmak Lermi, Max Molina Ayala, Sharia Hernandez Ruiz, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Comparison of imaging-based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed, paraffin-embedded tumor samplesNejla Ozirmak Lermi, Max Molina Ayala, Sharia Hernandez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2013
Comprehensive biomarker analysis and final efficacy results of sorafenib in the BATTLE trialGeorge R Blumenschein, Pierre Saintigny, Suyu Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2016
The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung CancerVassiliki Papadimitrakopoulou, J Jack Lee, Ignacio I Wistuba, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Oncotarget|October 20, 2018
Concomitant targeting of the mTOR/MAPK pathways: novel therapeutic strategy in subsets of <i>RICTOR/KRAS</i>-altered non-small cell lung cancerDennis Ruder, Vassiliki Papadimitrakopoulou, Kazuhiko Shien, et al.
Cell Reports|November 18, 2023
Stabilizing vimentin phosphorylation inhibits stem-like cell properties and metastasis of hybrid epithelial/mesenchymal carcinomasNick A Kuburich, Petra den Hollander, Maria Castaneda, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 25, 2019
Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinomaRoberto Ruiz-Cordero, Priya Rao, Lerong Li, et al.
Cancer Discovery|May 16, 2012
The BATTLE trial: personalizing therapy for lung cancerEdward S Kim, Roy S Herbst, Ignacio I Wistuba, et al.
Nature Communications|September 26, 2025
Comparison of imaging based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed paraffin-embedded tumor samplesNejla Ozirmak Lermi, Max Molina Ayala, Sharia Hernandez, et al.
JAMA Oncology|November 6, 2015
Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical TrialWilliam N William, Vassiliki Papadimitrakopoulou, J Jack Lee, et al.
Research Square|January 29, 2025
Comparison of imaging-based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed, paraffin-embedded tumor samplesNejla Ozirmak Lermi, Max Molina Ayala, Sharia Hernandez Ruiz, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Comparison of imaging-based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed, paraffin-embedded tumor samplesNejla Ozirmak Lermi, Max Molina Ayala, Sharia Hernandez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2013
Comprehensive biomarker analysis and final efficacy results of sorafenib in the BATTLE trialGeorge R Blumenschein, Pierre Saintigny, Suyu Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2016
The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung CancerVassiliki Papadimitrakopoulou, J Jack Lee, Ignacio I Wistuba, et al.
Pageof 9